We are serving since 1907 For product complaints and adverse events, toll-free number 1-866-210-9797
info@alembicusa.com908-393-9604
At Alembic, quality is the way of life. It is not just about SOPs and the hardware. It is an encompassing culture that is the foundation of all business decisions.
More than a century ago, with the guidance and support of his Highness Maharaja Sayajirao Gaekwad, a great mind with business acumen...
Our generic R&D activities are carried out at two R&D centers based in India. We are focused on the development of complex, difficult to produce, high-value treatment options to address the unmet needs of patients and improve health outcomes. More...
Our state-of-the-art manufacturing facilities feature the most advanced technology and quality systems to ensure the delivery of quality products at the appropriate time. More...
Bedminster, NJ – Alembic Pharmaceuticals, Inc., is a subsidiary of Alembic Pharmaceuticals Ltd., the oldest pharmaceutical company in India. Alembic Pharmaceuticals Limited., employs more than 8000 people and is one of the most respected, established, and integrated pharmaceutical companies in Asia, supplying products to more than 90 countries around the world. Alembic Pharmaceuticals Ltd., is listed on the Bombay Stock Exchange under the stock symbol APLLTD.
Alembic is a vertically integrated organization, with expertise spanning the entire pharmaceuticals value chain: Research & Development (R&D), Manufacturing and Marketing of finished dosage formulations, as well as active pharmaceutical ingredients and intermediates.
More than a century ago, with the guidance and support of his Highness Maharaja Sayajirao Gaekwad, a great mind with business acumen along with two geniuses of Chemistry, conceived Alembic Chemical Works Company Limited.
Jul 03, 2025
Alembic Pharmaceuticals Inc., a wholly owned subsidiary of Alembic Pharmaceuticals Limited, has acquired a 100 percent stake in Utility Therapeutics Ltd, a pharmaceutical company focused on treatments for urinary tract infections (UTIs).Utility Therapeutics is involved in the development and approval of two brand pharmaceutical products for the treatment of urinary tract infections (UTI). -“Pivya” is an FDA approved product to treat uncomplicated UTIs in the US market. -“MEC” is a product in development for the treatment of complicated UTIs in the US market.
Aug 06, 2018
Received USFDA Tentative Approval for Bimatoprost Ophthalmic Solution, 0.03% More...
Jul 14, 2017
An Anti Cancer Drug Manufacturing Unit at Panelav, Halol, Near Vadodara was Inaugurated by Chief Minister of Gujarat Mr. Vijay Rupani on 14th Jul 2017 More...
Mar 08, 2017
BW article - India's Most Valuable CEO's More...
Oct 24, 2016
ANDA: 'Supplier of the year 2016' by ANDA USA More...
Nov 09, 2016
FORBES AWARD: Forbes India Awards Mr Pranav Amin and Mr. Shaunak Amin as 'NextGen Entrepreneurs of the Year' More...